Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) On October 10, 2008, Jerry C. Benjamin and Lawrence G. Meyer were appointed to the Board of Directors of IVAX Diagnostics, Inc. (the "Company"). Messrs. Benjamin and Meyer filled two of the three vacancies on the Board of Directors of the Company created by the previously reported resignations, effective as of October 10, 2008, of Fernando Fernandez, Glenn Halpryn and Jose Valdes-Fauli. In addition to their appointments to the Board of Directors, Mr. Benjamin was appointed to the Audit Committee of the Company, and Mr. Meyer was appointed to the Audit and Compensation Committees of the Company.

In connection with their respective appointments to the Board of Directors, each of Messrs. Benjamin and Meyer was granted options under the Company's 1999 Performance Equity Plan to purchase 25,000 shares of the Company's common stock at an exercise price of $0.50 per share, which equaled the closing price of a share of the Company's common stock on the American Stock Exchange on October 10, 2008. In addition to these stock option grants, Mr. Benjamin was awarded an aggregate annual cash retainer of $27,500 for his appointment to the Board of Directors and Audit Committee of the Company, and Mr. Meyer was awarded an aggregate annual cash retainer of $32,500 for his appointment to the Board of Directors and Audit and Compensation Committees of the Company. These annual cash retainers are expected to be paid in equal quarterly installments. Each of these stock option grants and annual cash retainer awards were made in accordance with the Company's current director compensation practices.

---